»ó´Ü¿©¹é
±â»ç (Àüü 59,484°Ç)
ÄɾîÁ¨, °á»ê½ÇÀû°ø½Ã ¿¹°í(10/31) ¹Úº´¿ì ±âÀÚ 2018-10-31 10:03
Àϵ¿Á¦¾à ¾Æ·Î³ª¹Î, Çѱ¹±¤°íÇÐȸ '¿ÃÇØÀÇ ºê·£µå»ó' ¼ö»ó ±è»ç¶û ±âÀÚ 2018-10-31 09:50
ÅøÁ¨, JP¸ð°Ç ÇコÄɾî ÄÁÆÛ·±½º 2³â ¿¬¼Ó ÃÊû ¹Þ¾Æ ±è»ç¶û ±âÀÚ 2018-10-31 09:45
¾ÆÀÌÁø, 'ÀÌÁö-µ¥ÄÚ¸°¡¯ ÀÓ»ó 2a»ó½ÃÇè °èȹ ½Ä¾àó ½ÂÀÎ ¹Úº´¿ì ±âÀÚ 2018-10-31 09:43
Á¦¾à-SK Pharma Weekly(10.24~30) ±è»ç¶û ±âÀÚ 2018-10-31 09:38
¶óÀÎ
ÇコÄɾî Daily(10/31)-½ÅÇѱÝÀ¶ÅõÀÚ(10/30) ¹Úº´¿ì ±âÀÚ 2018-10-31 09:33
¾ÆÀ̼¾½º, ¹Ý°¡¿î ¾î´× ¼­ÇÁ¶óÀÌÁî ¹Úº´¿ì ±âÀÚ 2018-10-31 09:31
Æĸ¶¸®¼­Ä¡ÇÁ·Î´öÆ®,¿µÅä È®Àå Áغñ¸¦ ¸¶ÃÆ´Ù ¹Úº´¿ì ±âÀÚ 2018-10-31 09:24
¼¿Æ®¸®¿ÂÇコÄɾî, ¼¿Æ®¸®¿ÂÇコÄÉ¾î ¿ÃÇØ°¡ ¹Ù´Ú ±è»ç¶û ±âÀÚ 2018-10-31 09:17
¼¿Æ®¸®¿Â, ¹Ì±¹ ÀÎÇ÷ºÆ®¶ó(·¥½Ã¸¶) ¸ÅÃâ¾× ÀüºÐ±â ´ëºñ 12.7% ¼ºÀå ¹Úº´¿ì ±âÀÚ 2018-10-31 09:11
¶óÀÎ
Á¾±Ù´ç, 3Q18 ÇÁ¸®ºä ¹Úº´¿ì ±âÀÚ 2018-10-31 09:08
À¯ÇѾçÇà, 3Q18 Review: ¾î´× ¼îÅ© ±è»ç¶û ±âÀÚ 2018-10-31 09:04
³ì½ÊÀÚ, ÇØ¿Ü »ç¾÷Àº ¼ºÀå¼¼ ±è»ç¶û ±âÀÚ 2018-10-31 09:00
µ¿¾Æ¿¡½ºÆ¼,ÅϾî¶ó¿îµå ±â´ë°¨ À¯È¿ ±è»ç¶û ±âÀÚ 2018-10-31 08:47
À¯ÇѾçÇà, R&D ¼º°ú µå·¯³ª°í ÀÖ´Ù. ¹ë·ù¿¡ÀÌ¼Ç Áõ°¡ Àü¸Á ¹Úº´¿ì ±âÀÚ 2018-10-31 08:40
¶óÀÎ
Á¦³ë·¹ÀÌ, ¡®19³â ´õ ÁÁ¾ÆÁø´Ù ¹Úº´¿ì ±âÀÚ 2018-10-31 08:34
¿¤¾Ø¾¾¹ÙÀÌ¿À ÄÚ½º´Ú ½Å±Ô»óÀå-11¿ù 1ÀϺÎÅÍ °Å·¡ °³½Ã ¹Úº´¿ì ±âÀÚ 2018-10-31 02:29
´ëÇѼҾưúÇÐȸÀå¿¡ È«¿µ¹Ì±³¼ö ÆʽºÅ¹ 2018-10-31 02:21
¼ÛÁÖÇÑ ¿¬¼¼´ë ÀÇ°ú´ëÇРȣÈí±â³»°ú ±³¼ö ºÎÄ£»ó ÆʽºÅ¹ 2018-10-31 02:20
¼¿·ç¸Þµå, Àüȯ°¡¾×ÀÇ Á¶Á¤(10/30) ¹Úº´¿ì ±âÀÚ 2018-10-31 02:18
Back to Top